Edwards Sapien Transcatheter Heart Valve and Transapical and Transfemoral Accessories
FDA PMAClass III (US FDA PMA)
Identity
- Trade Name
- EDWARDS SAPIEN TRANSCATHETER HEART VALVE AND ACCESSORIES FDA PMA
- Generic Name
- Aortic valve, prosthesis, percutaneously delivered FDA PMA
Identifiers
- PMA Number
- P110021 FDA PMA
- FDA Product Code
- NPT FDA PMA
Classification
- Device Class
- Class III FDA PMA
- Advisory Committee
- Cardiovascular FDA PMA
- FDA Decision
- APWD FDA PMA
The Edwards Sapien transcatheter heart valve is a percutaneous aortic valve prosthesis indicated for transapical and transfemoral delivery in patients with severe symptomatic calcified native aortic valve stenosis. It is supplied as model 9000TFX in sizes 23 mm and 26 mm, accompanied by the Ascendra balloon catheter for transapidal delivery and the Retroflex 3 delivery system for transfemoral delivery.
This device is intended for use in patients with ejection fraction >= 20% who have been evaluated by a heart team and are either inoperable or at high risk for surgical aortic valve replacement, with a Society of Thoracic Surgeons operative risk score >= 8% or judged to be at >=15% mortality risk. It is a Class III device authorized under FDA PMA P110021 and is supplied sterile for single-use implantation.
Frequently asked questions
What sizes are available for the Edwards Sapien transcatheter heart valve model 9000TFX?
The Edwards Sapien transcatheter heart valve model 9000TFX is available in sizes 23 mm and 26 mm, as specified in the approval documentation for both transapical and transfemoral delivery.
Is the Edwards Sapien transcatheter heart valve approved for use in patients with severe aortic insufficiency?
No, the device is indicated only for patients with severe symptomatic calcified native aortic valve stenosis without severe aortic insufficiency, as stated in the indications for both transapical and transfemoral delivery pathways.
What delivery systems are included with the Edwards Sapien transcatheter heart valve and accessories?
The system includes the Ascendra balloon catheter for transapical delivery and the Retroflex 3 delivery system for transfemoral delivery of the Edwards Sapien transcatheter heart valve model 9000TFX.
This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Edwards Lifesciences – the leading global structural heart innovation ..., Edwards Lifesciences – the leading global structural heart innovation ..., Edwards Lifesciences – Wikipedia, Edwards Lifesciences - Wikipedia, Edwards Lifesciences - Herzmedizin.de
Authorization Coverage (1 country)
Regulatory Authorizations
FDA_PMA
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA PMA | United States | FDA_PMA | P110021 | Class III | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Edwards Lifesciences LLC
- FDA Applicant
- Edwards Lifesciences, LLC
Sources (1)
- FDA PMA P110021 24 fields · synced Sep 18, 2026